富祥药业(300497.SZ)：正在扩大哌拉西林产品产能

Core Viewpoint - Fuxiang Pharmaceutical is expanding the production capacity of Piperacillin, which is a mainstream product in the market with broad demand [1] Group 1 - The company is focusing on increasing the capacity for Piperacillin production [1] - Piperacillin can be combined with Tazobactam and Sulbactam to form compound preparations, making it a popular choice in the market [1] - The demand for these products is significant, indicating a strong market opportunity for the company [1]